Rchr
J-GLOBAL ID：202201019720628256
Update date: Apr. 14, 2024
Masui Koji
マスイ コウジ | Masui Koji
Affiliation and department：
Job title：
Assistant Professor
Research theme for competitive and other funds (8)：
- 2022 - 2025 Development of a Monte Carlo-based dose distribution verification system for HDR brachytherapy.
- 2021 - 2024 Development and evaluation of adaptive radiotherapy for cervical cancer using IMRT and interstitial brachytherapy for international standardization
- 2020 - 2023 dummy
- 2018 - 2023 空間把握能力を持ったCTガイド下穿刺補助デバイスの開発
- 2018 - 2023 Development of quality assurance of high dose rate brachytherapy using 3D polymer gel dosimeter
- 2017 - 2023 正確な小線源治療を担保するリアルタイムIn vivo dosimetryの開発
- 2017 - 2023 Development of optimal interstitial brachytherapy for image guided brachytherapy of uterin cervix cancer.
- 2018 - 2021 Development of inexpensive and simple quantitative evaluation system for radiation dermatitis
Show all
Papers (96)：
-
Hideya Yamazaki, Gen Suzuki, Koji Masui, Norihiro Aibe, Takuya Kimoto, Kei Yamada, Koji Okihara, Fumiya Hongo, Masayoshi Okumi, Takumi Shiraishi, et al. The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy. Scientific reports. 2024. 14. 1. 8011-8011
-
Fumiaki Isohashi, Ken Yoshida, Naoya Murakami, Koji Masui, Shunichi Ishihara, Yu Ohkubo, Yuko Kaneyasu, Rumiko Kinoshita, Tadayuki Kotsuma, Yuji Takaoka, et al. Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024. 110269-110269
-
Hideya Yamazaki, Gen Suzuki, Koji Masui, Kei Yamada, Takashi Ueda, Takumi Shiraishi, Atsuko Fujihara, Takashi Kato, Yasutoshi Hashimoto, Haruumi Okabe. Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer. Cancers. 2023. 15. 23
-
Akihiro Nakashima, Hideya Yamazaki, Gen Suzuki, Kei Yamada, Aibe Norihiro, Takuya Kimoto, Koji Masui, Katsuhiko Nakatsuka, Tetsuya Taguchi, Yasuto Naoi. The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery. Cureus. 2023. 15. 11. e48187
-
Tadashi Takenaka, Hideya Yamazaki, Gen Suzuki, Koji Masui, Daisuke Shimizu, Tadayuki Kotsuma, Eiichi Tanaka, Ken Yoshida, Kei Yamada. Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy. Journal of contemporary brachytherapy. 2023. 15. 3. 191-197
ｍore...
MISC (2)：
-
相部 則博, 吉田 秀樹, 木元 拓也, 増井 浩二, 清水 大介, 西村 岳, 川畑 加奈子, 鈴木 弦, 山崎 秀哉, 宮地 充, et al. 京都府立医科大学における小児がんに対する陽子線治療の初期経験. 日本小児血液・がん学会雑誌. 2019. 56. 4. 336-336
-
Radiotherapy for Cervical Cancer : From Two Dimensional Treatment Planning to Three Dimensional Treatment Planning and Image Guided Brachytherapy. 2014. 123. 5. 347-353
Return to Previous Page
